Statin therapy considered for thyroid eye disease

VANCOUVER, British Columbia — Statins show promise as a low-risk disease-modifying agent for treating thyroid eye disease, for which smoking is seen as the only modifiable risk factor. A hyperosmotic shift of fluid into orbital tissue is associated with thyroid eye disease, and the resultant inflammatory state can last for 1 to 2 years, Andrew L. Reynolds, MD, said at the American Association for Pediatric Ophthalmology and Strabismus meeting